Spyre Therapeutics: Q4 Earnings Snapshot
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a ...
ZoomInfo CEO says he is buying more stock as shares explode more than 20% higher
An earnings-driven stock surge for ZoomInfo (ZI) isn't stopping its founder and CEO from signing off on more aggressive share ...
Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...
Hosted on MSN5d
UBS Upgrades RTX (RTX)
Fintel reports that on February 24, 2025, UBS upgraded their outlook for RTX (NYSE:RTX) from Neutral to Buy. Analyst Price ...